Early research (Phase 1)Study completedNCT03739554
What this trial is testing
CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL
Who this might be right for
Relapsed or Refractory Chronic Lymphocytic Leukemia
Cyclacel Pharmaceuticals, Inc. 5